EUDA Health Holdings Ltd (EUDA)
EUDA Health Holdings Ltd is a Singapore-headquartered healthcare company listed on NASDAQ as common stock under the ticker EUDA. The company focuses on non-invasive healthcare services, with operations primarily in Singapore, Malaysia, and China. Its service and product offerings include bioenergy capsule services, stem cell therapy, CRISPR gene editing treatment services, and supplements. In addition to healthcare-related activities, EUDA also provides property management services. The business is organized as a public company rather than a fund or a specialty security, and its listing reflects ordinary common equity in the issuer.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-EUDA
|
$13.80
|
-10.4% Downside
|
Fair
|
$55
|
257.4% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 21, 2026
|
-14.7x
|
-9.6x
|
6.0x
|
40.783 M
|
42.826 M
|
5.6%
|
58.8%
|
-139.1
|
—
|
90.3%
|
